|
MechanismOrexin receptor antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CA |
First Approval Date03 Sep 2019 |
100 Clinical Results associated with Eisai (Hong Kong) Co., Ltd.
0 Patents (Medical) associated with Eisai (Hong Kong) Co., Ltd.
100 Deals associated with Eisai (Hong Kong) Co., Ltd.
100 Translational Medicine associated with Eisai (Hong Kong) Co., Ltd.